Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19

Karin Hardt, An Vandebosch, Jerry Sadoff, Mathieu Le Gars, Carla Truyers, David Lowson, Ilse Van Dromme, Johan Vingerhoets, Tobias Kamphuis, Gert Scheper, Javier Ruiz-Guiñazú, Saul N. Faust, Christoph D. Spinner, Hanneke Schuitemaker, Johan Van Hoof, Macaya Douoguih, Frank Struyf, the ENSEMBLE2 Study Group
doi: https://doi.org/10.1101/2022.01.28.22270043
Karin Hardt
1Janssen Research and Development, Beerse, Belgium
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
An Vandebosch
1Janssen Research and Development, Beerse, Belgium
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry Sadoff
2Janssen Vaccines and Prevention, Leiden, The Netherlands
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathieu Le Gars
2Janssen Vaccines and Prevention, Leiden, The Netherlands
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carla Truyers
1Janssen Research and Development, Beerse, Belgium
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Lowson
3Janssen Research and Development, High Wycombe, UK
M.Sc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilse Van Dromme
1Janssen Research and Development, Beerse, Belgium
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johan Vingerhoets
1Janssen Research and Development, Beerse, Belgium
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Kamphuis
2Janssen Vaccines and Prevention, Leiden, The Netherlands
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gert Scheper
2Janssen Vaccines and Prevention, Leiden, The Netherlands
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Ruiz-Guiñazú
1Janssen Research and Development, Beerse, Belgium
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saul N. Faust
4NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK
F.R.C.P.C.H.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph D. Spinner
5Technical University of Munich, Munich, Germany
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanneke Schuitemaker
2Janssen Vaccines and Prevention, Leiden, The Netherlands
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johan Van Hoof
2Janssen Vaccines and Prevention, Leiden, The Netherlands
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Macaya Douoguih
2Janssen Vaccines and Prevention, Leiden, The Netherlands
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Struyf
1Janssen Research and Development, Beerse, Belgium
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: FStruyf{at}ITS.JNJ.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2022.01.28.22270043
History 
  • January 31, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Karin Hardt, Ph.D.1,
  2. An Vandebosch, Ph.D.1,
  3. Jerry Sadoff, M.D.2,
  4. Mathieu Le Gars, Ph.D.2,
  5. Carla Truyers, Ph.D.1,
  6. David Lowson, M.Sc.3,
  7. Ilse Van Dromme, Ph.D.1,
  8. Johan Vingerhoets, Ph.D.1,
  9. Tobias Kamphuis, Ph.D.2,
  10. Gert Scheper, Ph.D.2,
  11. Javier Ruiz-Guiñazú, M.D.1,
  12. Saul N. Faust, F.R.C.P.C.H.4,
  13. Christoph D. Spinner, M.D.5,
  14. Hanneke Schuitemaker, Ph.D.2,
  15. Johan Van Hoof, M.D.2,
  16. Macaya Douoguih, M.D.2,
  17. Frank Struyf, M.D.1,*,
  18. the ENSEMBLE2 Study Group
  1. 1Janssen Research and Development, Beerse, Belgium
  2. 2Janssen Vaccines and Prevention, Leiden, The Netherlands
  3. 3Janssen Research and Development, High Wycombe, UK
  4. 4NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK
  5. 5Technical University of Munich, Munich, Germany
  1. ↵*Corresponding Author:
    Frank Struyf, M.D.; Email: FStruyf{at}ITS.JNJ.com
Back to top
PreviousNext
Posted January 31, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
Karin Hardt, An Vandebosch, Jerry Sadoff, Mathieu Le Gars, Carla Truyers, David Lowson, Ilse Van Dromme, Johan Vingerhoets, Tobias Kamphuis, Gert Scheper, Javier Ruiz-Guiñazú, Saul N. Faust, Christoph D. Spinner, Hanneke Schuitemaker, Johan Van Hoof, Macaya Douoguih, Frank Struyf, the ENSEMBLE2 Study Group
medRxiv 2022.01.28.22270043; doi: https://doi.org/10.1101/2022.01.28.22270043
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
Karin Hardt, An Vandebosch, Jerry Sadoff, Mathieu Le Gars, Carla Truyers, David Lowson, Ilse Van Dromme, Johan Vingerhoets, Tobias Kamphuis, Gert Scheper, Javier Ruiz-Guiñazú, Saul N. Faust, Christoph D. Spinner, Hanneke Schuitemaker, Johan Van Hoof, Macaya Douoguih, Frank Struyf, the ENSEMBLE2 Study Group
medRxiv 2022.01.28.22270043; doi: https://doi.org/10.1101/2022.01.28.22270043

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)